Company news
Proteomics International Laboratories Ltd. news in 2020
Proteomics International Laboratories Ltd.'s news releases, calls and decks from 2020, newest first.
AGM Investor Presentation
November 25, 2020
Middle East is next market for PromarkerD immunoassay test
November 11, 2020
PromarkerD clinical assay performance results published
November 4, 2020
Proteomics receives $1.1 million in R&D tax incentive
November 2, 2020
Completion of Placement and Appendix 2A
November 1, 2020
September 2020 Quarterly Activities Report and Appendix 4C
October 27, 2020
Proteomics International raises $6m in successful Placement
October 22, 2020
First distribution agreement for PromarkerD immunoassay
October 15, 2020
Partnership with QIMR Berghofer targets oesophageal cancer
October 8, 2020
June 2020 Quarterly Activities Report and Appendix 4C
July 28, 2020
PromarkerD Intellectual Property portfolio expands
July 27, 2020
Appendix 3Y - Directors on-market purchase of shares
June 28, 2020
Big pharma clinical study validates PromarkerD kidney test
June 14, 2020
Updated Investor Presentation
June 9, 2020
Proteomics International receives COVID-19 research grants
May 25, 2020
Appendix 4C and Quarterly Report - March 2020
April 27, 2020
CE Mark for Proteomics PromarkerD Immunoassay Kit
April 15, 2020
Proteomics expands diagnostics R&D - the Promarker Pipeline
April 7, 2020
Proteomics International expands study with US big pharma
March 30, 2020
Proteomics patents biomarkers for diagnosis of endometriosis
March 22, 2020
Appendix 4C - December 2019 Quarterly Report
January 28, 2020
CE Mark for PromarkerD Hub predictive software for DKD
January 13, 2020
Decks in 2020
- Shareholder Meeting (November 2020)
Shareholder meeting · 24 slides · Nov 26, 2020
- Investor Presentation (August 2020)
Investor deck · 22 slides · Aug 26, 2020
- Investor Presentation (June 2020)
Investor deck · 23 slides · Jun 9, 2020